- Home
- VRNA vs ESE Comparison
VRNA vs ESE Comparison
Compare VRNA & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- ESE
- Stock Information
- Founded
- VRNA 2005
- ESE 1990
- Country
- VRNA United Kingdom
- ESE United States
- Employees
- VRNA N/A
- ESE N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- ESE Telecommunications Equipment
- Sector
- VRNA Health Care
- ESE Telecommunications
- Exchange
- VRNA Nasdaq
- ESE Nasdaq
- Market Cap
- VRNA 3.4B
- ESE 3.4B
- IPO Year
- VRNA 2017
- ESE N/A
- Fundamental
- Price
- VRNA $67.96
- ESE $162.12
- Analyst Decision
- VRNA Strong Buy
- ESE Strong Buy
- Analyst Count
- VRNA 7
- ESE 2
- Target Price
- VRNA $57.14
- ESE $147.50
- AVG Volume (30 Days)
- VRNA 1.3M
- ESE 125.6K
- Earning Date
- VRNA 02-27-2025
- ESE 02-06-2025
- Dividend Yield
- VRNA N/A
- ESE 0.19%
- EPS Growth
- VRNA N/A
- ESE 18.29
- EPS
- VRNA N/A
- ESE 4.26
- Revenue
- VRNA $5,624,000.00
- ESE $1,055,471,000.00
- Revenue This Year
- VRNA N/A
- ESE $14.05
- Revenue Next Year
- VRNA $571.44
- ESE $11.19
- P/E Ratio
- VRNA N/A
- ESE $40.07
- Revenue Growth
- VRNA 1127.95
- ESE 8.94
- 52 Week Low
- VRNA $11.39
- ESE $97.11
- 52 Week High
- VRNA $68.64
- ESE $171.28
- Technical
- Relative Strength Index (RSI)
- VRNA 76.88
- ESE 65.15
- Support Level
- VRNA $62.24
- ESE $160.23
- Resistance Level
- VRNA $65.50
- ESE $167.61
- Average True Range (ATR)
- VRNA 2.78
- ESE 6.00
- MACD
- VRNA 0.22
- ESE 1.88
- Stochastic Oscillator
- VRNA 94.86
- ESE 79.56
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG) and RF Shielding and Test (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure and contain magnetic, electromagnetic and acoustic energy.